STOCK TITAN

Weight Watchers and CheqUp Expand Partnership To Deliver Holistic Support for Weight Health in the UK

(Neutral)
(Positive)
Tags
partnership

Weight Watchers (Nasdaq: WW) and CheqUp are expanding their UK partnership to integrate behavioural and clinical weight management. CheqUp becomes the dedicated partner for medical weight-loss treatment, while UK members gain streamlined access to CheqUp consultations plus the Weight Watchers app, Core+ plan and GLP-1 Companion Programme.

According to Weight Watchers, 85% of GLP-1 Companion Programme U.S. members say it makes getting healthy easier and 81% call Weight Watchers the perfect partner on their GLP-1 journey.

Loading...
Loading translation...

Positive

  • Expanded WW–CheqUp partnership integrates behavioural and clinical weight management in the UK
  • CheqUp becomes dedicated UK partner for Weight Watchers members’ medical weight-loss treatment
  • UK Weight Watchers members can access CheqUp consultations directly from the Weight Watchers website
  • CheqUp members receive complimentary access to the Weight Watchers app and Core+ programme
  • CheqUp members also get the Weight Watchers GLP-1 Companion Programme where applicable
  • Customer survey: 85% of U.S. GLP-1 Companion members say Weight Watchers makes it easier to get healthy
  • Customer survey: 81% of U.S. GLP-1 Companion members describe Weight Watchers as the perfect GLP-1 partner

Negative

  • None.

News Market Reaction – WW

+0.47%
1 alert
+0.47% Session close to close
$196.28M Market Cap
0.0x Rel. Volume

In the Jun 17 session, WW gained 0.47%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement deepens WW’s UK relationship with CheqUp, linking its behavioural programmes and G...
Analysis

This announcement deepens WW’s UK relationship with CheqUp, linking its behavioural programmes and GLP-1 Companion support with CheqUp’s clinical services. The move mirrors WW’s broader strategy of GLP-1-centric partnerships seen over 2025–2026, aiming for integrated medical and behavioural weight management. Investors may track member engagement in the UK, evolution of NHS weight-medication access, and how effectively WW converts this collaboration into sustained subscription and clinical-program traction.

Key Figures

GLP-1 Companion satisfaction: 85% GLP-1 partner fit: 81% NHS eligibility expansion: more than a million people +3 more
6 metrics
GLP-1 Companion satisfaction 85% U.S. GLP-1 Companion Programme members saying WW makes it easier to get healthy
GLP-1 partner fit 81% U.S. GLP-1 Companion Programme members calling WW the perfect GLP-1 partner
NHS eligibility expansion more than a million people England patients with heart health issues newly eligible for weight-loss medications
Programme pillars 4 GLP-1 Companion Programme pillars: nutrition, medication tracking, strength, community
CheqUp access all CheqUp members Receive complimentary access to WW app and GLP-1 Companion Programme
Study reference 12 months WW Clinic data cited for body weight reduction timeline in prior UK partnership

Previous Partnership Reports

3 past events · Latest: Feb 10 (Positive)
Same Type Pattern 3 events
Date Event Sentiment 24h Move Catalyst
Feb 10 Fitness partnership Positive -2.1% Announced PVOLVE partnership adding strength and mobility workouts to WW programs.
Oct 20 Pharmacy collaboration Positive +9.3% Teamed with Amazon Pharmacy to speed GLP-1 and weight-medication access.
May 22 Initial CheqUp deal Positive +15925.6% Launched UK GLP-1-focused partnership giving CheqUp members WW support tools.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Partnership announcements have generally seen positive price reactions, with one notable negative divergence.

Recent Company History

Over the past year, WW has repeatedly used partnerships to deepen its weight-health ecosystem. The February 2026 PVOLVE deal added clinically validated strength and mobility workouts across multiple WW tracks. In October 2025, collaboration with Amazon Pharmacy targeted faster, more convenient GLP-1 medication delivery. A May 2025 CheqUp partnership focused on GLP-1-based weight loss in the UK. Today’s UK-focused CheqUp expansion builds directly on that prior collaboration theme.

Key Terms

glp-1
1 terms
glp-1 medical
"Weight Watchers GLP-1 Companion Programme which has been specifically designed to support people"
GLP-1 (glucagon-like peptide-1) is a natural hormone in the body that helps regulate blood sugar levels and appetite. Its significance to investors lies in its role as the basis for a class of medications that address conditions like type 2 diabetes and obesity, which are large and growing markets. Advances or investments in GLP-1-based treatments can signal opportunities in healthcare innovation and potentially impact pharmaceutical companies’ growth.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

The collaboration brings clinical and behavioural weight management together, offering UK members a more integrated path to sustainable weight loss.

CheqUp becomes the dedicated partner for weight-loss treatment, including access to CheqUp’s clinical service in the UK, mirroring the integrated clinical model in the US.

NEW YORK, June 16, 2026 (GLOBE NEWSWIRE) -- WW International, Inc (Nasdaq: WW) (“Weight Watchers”), the global leader in science-backed weight management, and CheqUp, the UK’s leading digital weight health platform, today announced a significant expansion of their partnership, bringing together best-in-class behavioural and clinical support for people on a weight management journey in the UK.

The two organisations first joined forces to offer Weight Watchers’ market-leading behavioural programme to CheqUp members in 2025. Now, the relationship is evolving into a more integrated, two-way partnership. Weight Watchers members in the UK will be able to access a CheqUp consultation seamlessly from the Weight Watchers website, enabling them to sign up to CheqUp's medical weight loss programme where clinically appropriate. Simultaneously, all CheqUp members will continue to receive access to the Weight Watchers app and Weight Watchers Core+ programme. Where applicable this includes Weight Watchers GLP-1 Companion Programme which has been specifically designed to support people taking weight-loss medication, with guidance from experts on food recommendations while supporting healthy weight loss.

The announcement comes as the National Health Service (NHS) recently expanded access to weight-loss medications to more than a million people in England with heart health issues1, reflecting growing recognition that GLP-1 medication can meaningfully reduce the risk of serious conditions such as heart attacks and strokes. Weight Watchers and CheqUp are aligned in their belief that medication is only one part of the answer. Long-term progress requires clinical oversight, behaviour change and a broader understanding of health markers all working in tandem.

A More Connected Weight Health Experience

For CheqUp members, the Weight Watchers app forms part of a more connected health journey. The app provides daily accountability backed by decades of behavioural science, enabling users to track medication doses, nutrition intake and activity, and connecting seamlessly with devices including Apple Health, Fitbit and Garmin.

This integrated experience is designed to bring UK members closer to the holistic model already available to Weight Watchers members in the United States, where clinical and behavioural support have long been offered as a combined offering.

One Year On: The GLP-1 Companion Programme Continues to Deliver

Since its launch in the UK in May 2025, the Weight Watchers GLP-1 Companion Programme has become an essential companion for members using weight loss medication. Built around four core pillars – personalised nutrition, medication tracking, strength and muscle support, and community accountability – the programme has seen strong and growing engagement in the year since launch.

The results speak for themselves: 85% of GLP-1 Companion Programme U.S. members say Weight Watchers makes it easier to get healthy and 81% describe Weight Watchers as the perfect partner on their GLP-1 journey. All CheqUp members continue to benefit from full, complimentary access to this programme as part of the deepened partnership. These results are based on customer survey responses from US members who were taking GLP-1 medications.

“This expanded partnership represents a meaningful step forward in how we support members on their weight loss and health journey in the UK,” said Scott Honken, Chief Commercial Officer at Weight Watchers. “For too long, clinical and behavioural support have operated in silos, resulting in people falling through gaps. By deepening our relationship with CheqUp, we’re bringing together the best of both worlds: world-class medical weight loss programme access, combined with the behavioural science and community accountability that Weight Watchers is known for. This is what holistic weight health looks like in practice and we’re proud to be making it available to our UK members.”

“CheqUp was founded on the belief that sustainable weight health is never just about medication,” said Lisa Tookey, CEO of CheqUp. “It requires clinical rigour, behavioural support and a clear view of your wider health. The extension of our partnership with Weight Watchers reflects exactly that philosophy. Together, we’re building a more connected Weight Health ecosystem in the UK, bringing clinical treatment and behaviour change into a single, seamless experience. We’re delighted to be taking this next step with one of the most trusted names in weight management.”

Notes to editors:

1 Source: NHS England » Over a million people could be offered Wegovy to cut heart attack and stroke risk on the NHS

ABOUT WEIGHT WATCHERS
Weight Watchers is the global leader in science-backed weight management, offering an integrated support system built for the GLP-1 era that combines scientific expertise, medication, cutting-edge technology, and human connection. With more than 60 years of experience, Weight Watchers is the most studied commercial weight management program in the world, delivered through its No. 1 U.S. doctor-recommended weight-loss program. Its holistic, personalized approach also includes U.S.-based clinical interventions and access to GLP-1 medications when clinically appropriate, and a global network of coaches and community support. Since 1963, the company has led with science to deliver its members the personalized support they need to reach and sustain their goals. Members can access these solutions directly, or through Weight Watchers for Business’ full-spectrum platform for employers, health plans, and payers. In a landscape crowded with contradictory advice, isolating apps, and one-size-fits-all solutions, Weight Watchers offers a proven path forward that is rooted in research, grounded in empathy and designed to help every member feel better in their body and live a longer, healthier life. For more information, visit weightwatchers.com.

ABOUT CHEQUP
CheqUp is a leading provider of weight loss services in the UK. Their CheqUp method offers a range of treatment plans and the UK's most comprehensive support programme, which includes one-on-one coaching with experienced health coaches. CheqUp empowers individuals to take charge of their health through accessible and evidence-based solutions.

For media inquiries, please contact:

For investor inquiries, please contact:


FAQ

What did Weight Watchers (WW) announce about its CheqUp partnership on June 16, 2026?

Weight Watchers announced a significant expansion of its UK partnership with CheqUp, integrating behavioural and clinical weight management. According to Weight Watchers, CheqUp becomes the dedicated partner for medical weight-loss treatment while members gain streamlined access to consultations, the Weight Watchers app, Core+ and GLP-1 Companion support.

How will UK Weight Watchers (WW) members access CheqUp’s medical weight-loss programme?

UK Weight Watchers members will be able to access a CheqUp consultation seamlessly from the Weight Watchers website. According to Weight Watchers, this enables eligible members to sign up for CheqUp’s medical weight-loss programme where clinically appropriate, creating a more connected weight health journey across digital, clinical and behavioural support.

What benefits do CheqUp members receive from the expanded Weight Watchers (WW) partnership?

CheqUp members receive continued access to the Weight Watchers app and Core+ behavioural programme under the expanded partnership. According to Weight Watchers, CheqUp members also benefit from complimentary access to the GLP-1 Companion Programme where applicable, supporting nutrition, medication tracking, strength and community accountability alongside clinical treatment.

What is the Weight Watchers GLP-1 Companion Programme and who can access it through CheqUp?

The GLP-1 Companion Programme is a Weight Watchers offering for members using weight-loss medication, focused on holistic support. According to Weight Watchers, CheqUp members receive full, complimentary access, including personalised nutrition, medication tracking, strength and muscle support and community accountability integrated with Weight Watchers’ digital tools and behavioural science.

What results has the Weight Watchers (WW) GLP-1 Companion Programme shown so far?

Survey results indicate the GLP-1 Companion Programme is resonating with participating members. According to Weight Watchers, 85% of U.S. GLP-1 Companion members say Weight Watchers makes it easier to get healthy, and 81% describe Weight Watchers as the perfect partner on their GLP-1 journey.

How does the UK Weight Watchers and CheqUp model compare to Weight Watchers’ US integrated approach?

The expanded UK partnership aims to mirror Weight Watchers’ integrated clinical model already available in the US. According to Weight Watchers, UK members will see behavioural and clinical support offered together, with CheqUp delivering medical treatment and Weight Watchers providing app-based tracking, coaching and the GLP-1 Companion Programme.

How does the Weight Watchers (WW) and CheqUp partnership support people using GLP-1 medications in the UK?

The partnership combines clinical oversight from CheqUp with Weight Watchers’ GLP-1 Companion behavioural programme. According to Weight Watchers, members can track medication doses, nutrition and activity, while receiving personalised guidance, strength support and community accountability that complement GLP-1 treatment within a connected digital and clinical ecosystem.